Predicting Politics In The Cannabis Legalization Debate – Forbes

When Supreme Court Justice Clarence Thomas calls the federal government’s approach to cannabis policy a “contradictory and unstable state of affairs,” you know the calls for reform have reached the highest levels. But for many of us in the industry, we weren’t surprised by this timely statement from what some may consider an unlikely advocate for federal policy changes.

That’s because the cannabis industry is used to seeing government officials, on both sides of the aisle, support their state’s cannabis industry at different points in the legalization process. While it’s easy to assume Democrats are pro-legalization and Republicans are anti-legalization, recent history shows us politics can shift after a state legalizes cannabis. Often, the shift makes it more palatable for elected officials to extend a cooperative hand across the aisle. It is not uncommon for a conservative elected official to oppose legalization because they see it as criminal activity, and then reverse course after their state legalizes to support fewer regulations for cannabis businesses. Conversely, a liberal elected official might champion legalization on the basis of social and criminal justice reform, while later advocating for comprehensive regulations for cannabis businesses due to public health concerns.

When it comes to traditional political wrangling, predicting an elected official’s cannabis policy stance can be counter intuitive. It has defied party lines, and in many ways, risen above the hyper partisan politics of other topics like immigration, health care, and voting rights. But depending on the issue area focus of legalization, members of a given party may not agree on the best path forward.

Most recently – and for the first time in our country’s history – the Senate Majority Leader, a Democrat, unveiled a framework for legalization alongside two other Democratic Senators. But President Biden said even if a full legalization bill made it through Congress and to his desk he might veto it. And in his first 200 days in office, President Biden also prevented Washington D.C. from starting an adult-use cannabis market by withholding federal funds.

Still the President has repeatedly said he supports states’ rights when it comes to cannabis legalization. But in the states, much like on Capitol Hill, some Democrats aren’t comfortable opening legal markets without federal cover. For instance, Hawaii Democratic Governor David Ige and the Democratic supermajorities in both statehouse chambers held up legalization efforts this year due to concerns about its Schedule 1 substance distinction.


Meanwhile, the SAFE Banking Act, a bill to allow cannabis businesses access to banking services and no longer force them to operate in all cash, passed the U.S. House this year with a bipartisan vote of 321-101. The SAFE Banking Act also has a companion bill in the Senate with nine Republican cosponsors. Among them are Senators Roy Blunt (R-MO), Bill Cassidy (R-LA), Susan Collins (R-ME), and Steve Daines (R-MT), who hail from medical cannabis-friendly states.

But commonsense, bipartisan legislation like this should not come as a total surprise. Senate Republicans have a recent history of supporting cannabis legalization. Former U.S. Senator Cory Gardner, from my home state of Colorado, became a champion for state legalization programs on Capitol Hill several years after Colorado launched adult cannabis sales in 2014. And in 2018, he threatened to block all Department of Justice nominations after the Trump administration rescinded previous federal guidance, including the Cole Memo.

And in the states, ruby red Oklahoma has the largest medical cannabis market in the country with more licensed marijuana businesses than any other state and about 10% of its population registered as patients. The result of a successful ballot initiative, the Sooner State’s medical cannabis program is supported by its Republican-held legislature and Republican Governor Kevin Stitt.

For traditionally conservative Republicans, supporting their state’s cannabis legalization frameworks means supporting states’ rights, reduced regulatory burdens for businesses, and the success of a new industry in the free market. And for liberal Democrats, supporting this new industry means the opportunity to draft strong government regulations and support underrepresented minorities. So far, these seemingly counter intuitive political stances have led to more collaborative outcomes. Both parties have proven this is possible at the state level, and members of Congress and the President should endeavor to strike the same harmony at the federal level.

The Week In Weed: July 30, 2021 – Mondaq News Alerts

United States: The Week In Weed: July 30, 2021

To print this article, all you need is to be registered or login on

Welcome back to The Week in Weed, your Friday look at what’s
happening in the world of legalized marijuana.

We start off with an amendment to federal legislation that would
protect state-legal cannabis programs.  Then we move on to the
states, where Mississippi is holding hearings on medical
marijuana.  Ohio’s legislature may take up adult-use
legislation.  Could North Carolina also get in on the
action?  And finally, there’s a restaurant where lobsters
and cannabis mix.


An amendment to a federal appropriations bill protecting
state-legal cannabis programs from federal interference gathered some steam this week.  The
Blumenauer-McClintock-Norton-Lee amendment would prohibit Justice
Department funds from being used to enforce federal law against
marijuana in states where it is legal.  Additional cosponsors
have signed on to the language, and it could come up for a vote
next week.


Work on a medical cannabis program continues in the Magnolia State.  Lawmakers are hashing
out a bill that would establish a program similar to the one voters
approved last November.  The governor has indicated that he
will not call a special session to vote on the measure until he
sees a bill he will sign.


The Coalition to Treat Marijuana Like Alcohol wants to see
adult-use cannabis legalized in Ohio.  They are in the process
of submitting a summary of their proposed
legislation to the state’s Attorney General Dave Yost, along
with 1,000 signatures.  If he approves the measure, the group
will need to collect 133,000 signatures in order to compel the
legislature to consider it.


A medical cannabis program advanced in the North Carolina Senate
recently, passing through the body’s Finance Committee. 
It still has two more committees to get through, as well as a floor
vote, before it goes to the House.  Support has been strong so
far; we’ll see if the measure’s luck holds in future.


If you give cannabis to lobsters before cooking them, is that
more humane?  A Maine restaurant claims it is, and there may
be some science behind the idea.  Kudos to the Portland
Press-Herald for the excellent headline.

Stay safe and be well everyone – we’ll see you next

The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.

POPULAR ARTICLES ON: Cannabis & Hemp from United States

Trademarks Comparative Guide

Obhan & Associates

Trademarks Comparative Guide for the jurisdiction of India, check out our comparative guides section to compare across multiple countries

City Council will tackle faulty cannabis license map – WEHOville

After the Business License Commission hit the brakes on a new cannabis consumption lounge on Santa Monica Blvd. earlier this month, City Council will attempt to rectify the legal issue that tripped up the application at their meeting next week.

The owners of Fantom Flower expected a smooth discussion of the lounge they planned to open inside the former Flaming Saddles bar.

But a report by WEHOville showed that the location was clearly within a pre-drawn buffer zone forbidding cannabis businesses within 600 feet of West Hollywood Park, and that city staff had attempted to alter the zone’s boundaries before anyone could notice. The Business License Commission was not pleased, and the application was put on hold until City Council could review the problem.

City staff members are now recommending that the buffer zone around West Hollywood Park be re-centered on the only section of the park that they believe requires it — the southern parcel, where the Tiny Tots program will operate when it re-opens. City zoning laws prohibit cannabis businesses from operating within 600 feet of so-called “sensitive-use areas” — daycare facilities, youth centers, or schools within a park property. Parks themselves are not considered sensitive-use.

The agenda item also directs city staff to review the buffer zone map, a reference document that has been used by cannabis license applicants and the city since 2017, and to make any necessary updates as they arise.

Article Rating

Recent Study Finds Cannabis Aids Treatment-Resistant Depression And Alcohol Dependency – Forbes

Treatment-resistant depression is common. Around 30% of people with depressive disorders have a form of depression that is resistant to treatment offered by traditional pharmaceuticals. This means that mood stabilizers and SSRIs do not work to alleviate their depression symptoms.

A recent study out of the Journal of Psychopharmacology called “Cannabis-induced oceanic boundlessness” found that large doses of cannabis can help improve symptoms of treatment-resistant depression and other mental ailments, including distress related to cancer, and even dependence on cigarettes and alcohol.

The study’s author states that THC, the compound in cannabis that produces the majority of its psychoactive effects, is “comparable to those identified in trials of psilocybin that precede relief from cancer-related distress, treatment-resistant depression, alcohol problems, and cigarette dependence.”

The study found that high doses of cannabis resulted in 17-19% of people with treatment-resistant depression and distress reporting experiencing “breakthroughs” for the better in their mental health. Psilocybin was still reported as offering more positive mental “breakthroughs” for people with treatment-resistant depression, 59% of respondents.

The study defines this breakthrough or feeling of “oceanic boundlessness” as mystical experiences, which often proceed a change in mental health. These mystical-type experiences are measured by “unity, spirituality, and insightfulness on the 11-Dimension Altered States of Consciousness Questionnaire or comparable self-report scales,” its authors say.

SAGE JournalsCannabis-induced oceanic boundlessness – Mitch Earleywine, Luna F Ueno, Maha N Mian, Brianna R Altman, 2021


This study is not alone is examining notions about cannabis and mental health. Cannabis and its effect on mental health have had a sordid relationship in the science community for the past century, largely because cannabis was not allowed to be clinically researched. Even today, cannabis has restrictions in place by the DEA so that only cannabis grown in their labs could be researched, and that research could not be done on the cannabis being sold in legal markets in the U.S. In May of 2021, the DEA says it’s “nearing the end of its review” and will anticipate changes to research of cannabis.

Anxiety and depression are among the most common illnesses in the United States with an estimated 40 million people suffering from some form of mental issue. Experts say these numbers have only been compounded by the stress of the pandemic. In adolescents, an estimated 3.2 million 12-17 year-olds in the U.S. suffer from depression and over 17.3 million young adults over the age of 18-26. It is estimated that 30% of adults and 60.1% of adolescents who are depressed never receive treatment.

In today’s regulations for every medical marijuana legal state, not one of them lists depression as a qualifying condition for a medical card. Several states list PTSD and anxiety as mental health qualifying conditions, but depression has long been left out of the medical marijuana efficacy conversation. One study that gained lots of attention, but relies on less of a data pool than other studies cited here, is this 2019 study linking cannabis to higher rates of psychosis.

MORE FROM FORBESNew Study Shows Cannabis Reduces Inflammatory 'Storms' Caused By Covid-19

It’s not the only study that has come out on cannabis and mental health within recent years. A research paper “When they say weed causes depression, but it’s your fav antidepressant”: Knowledge-aware attention framework for relationship extraction.” This research team looks at self-reported data across Twitter and asks the question, is cannabis causing depression or is it a potential treatment for depression? Have people been self-medicating? It found that people do use cannabis for depression, but the paper is limited in that it doesn’t differentiate CBD and cannabis, so the anxiety and depression reduction effect cannot be pinpointed to cannabinoids CBD or THC separately. There are many studies that have found CBD reduces anxiety.

Additional research suggests that people who become adult medical marijuana patients may have self-medicated with cannabis to reduce their own depression and anxiety before it was legally prescribed to them.

The pandemic stress and trauma has increased American’s dire need for mental health solutions. One study “Adult PTSD symptoms and substance use during Wave 1 of the COVID-19 pandemic,” found that first wave of COVID-19 could be correlated to spikes in substance use. It found 13.4% of women and 13.2% of men reported significant substance use increase following the pandemic. The most “stressed” out of these people were adults aged 18-35, people who feel they contracted COVID, and also people who lost their jobs or incomes due to the pandemic.

Chicago businessmen awarded cannabis license for future Springfield dispensary – The State Journal-Register

A Black-owned marijuana dispensary is coming to Springfield.

Chicago businessmen Brian Scruggs and Kamau Murray of Herbal Quality Control LLC on Thursday were awarded a cannabis license by the Illinois Department of Financial and Professional Regulation to operate a recreational dispensary in Springfield. 

The dispensary will be the first of three licenses coming to Sangamon and Menard counties as part of the state’s three-round lottery, which has a renewed focus to award licenses to minorities and those with past marijuana-related convictions due to recent legislation.

More: Downhome Music Festival lineup, street closures, weather, other need-to-know information

„The outcome of the original scoring process prompted a reply that the results did not meet their original goal of social equity,” said Pamela Althoff, executive director of the Cannabis Business Association of Illinois and former state senator.

„It was the entire reason why the State of Illinois had the additional lottery,” Althoff said referring to a lack of licenses being awarded to those who were historically disenfranchised as a result of past marijuana laws. The drug became legal for recreational use in Illinois in 2020.

Earlier in July, Gov. JB Pritzker signed a bill into law that changes the state’s grading system for cannabis licenses to better promote minority applicants. A study by the American Civil Liberties Union found that Black people were 7.5 times more likely to be arrested for marijuana possession in Illinois prior to the drug’s legalization despite them using it at about the same rate as whites. 

Herbal Quality Control was awarded one of 75 licenses announced on Thursday. Those license awards were delayed more than a year during the COVID-19 pandemic.

More: New Illinois law aims to expand affordable housing through $75M investment, tax credits

A total of 110 licenses will be awarded by the state in August, with two slated to go toward operations in Sangamon and/or Menard counties. Preference for those licenses will be given to „social-equity” applicants, per recent legislation.

Social-equity applicants include entrepreneurs from low-income neighborhoods or those who have or are directly related to those with past marijuana convictions.

„We look forward to ensuring an inclusive and equitable cannabis program whose makeup accurately reflects the diversity of our great state of Illinois,” said IDFPR acting secretary Mario Treto Jr. in a news release.

More: Education services extended for special needs students in Illinois

Three additional licenses will be granted for a west-central Illinois region that includes the counties of Christian, Logan, Mason, Montgomery, Morgan and Schuyler with another three licenses going to a multi-county region of Illinois near St. Louis that includes Macoupin and Jersey counties.

It was announced on Thursday that licenses were awarded to Clean Slate OPCO LLC and Land of Lincoln Dispensary LLC to operate in Decatur and Bloomington, respectively.

Contact Riley Eubanks:,

Tilray’s war chest – Business Insider

Welcome to Insider Cannabis, our weekly newsletter where we’re bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom.

Sign up here to get it in your inbox every week.

Hello everyone,

Here on the home front, reports that Gov. Andrew Cuomo is slow-walking legalization — he has yet to make nominations for the Office of Cannabis Management — have raised eyebrows across the New York cannabis world.

The New York Post reported that the delay was because of Cuomo’s anger over the legislature’s lack of action on his proposed MTA legislation. Sen. Dianne Savino, who co-led the push for cannabis reform, said that she expects Cuomo to be able to „walk and roll a joint at the same time.”

Speaking from experience, that’s much harder than it looks.

What else happened? 

Yeji has a pair of stories in her series on what’s in store for the burgeoning psychedelics market. You should read those if you want to get quickly up to speed.

I published a deep dive into the promises and pitfalls of synthetic cannabinoids and the surprising amount of money being poured into research by startups. It’s expected to become a $115 billion market.

Tilray CEO Irwin Simon — fresh off a profitable quarter — told us in an interview that he’s got ambitious M&A plans for the US

– Jeremy Berke (@jfberke

If you like what you read, share this newsletter with your colleagues, friends, boss, spouse, strangers on the internet, or whomever else would like a weekly dose of cannabis news. 

Here’s what we wrote about this week:

Top psychedelics VCs predict a tech boom and a rise of clinics over the next year

Some of the top VCs in the psychedelics space told Insider that they predict a rise in psychedelic clinics and more companies focused on other areas that don’t involve drug development.

Biotechs are betting millions on unlocking the $115 billion synthetic-cannabis market

Growing quality cannabis isn’t easy. Biotech startups are chasing what Wall Street analysts say could become a $115 billion market for synthetic cannabis compounds. „It’s a biosynthesis revolution,” one cannabis biotech executive told Insider. „Biology is to the 21st century what physics was to the 20th.”

The CEO of cannabis giant Tilray is sitting on a $500 million war chest, and says he’s ready to make a deal for a US cannabis company

Tilray CEO Irwin Simon told Insider he’s not waiting on legalization to make a deal with a US company. Instead, the executive said he’s closely watching US cannabis companies with good assets and branding. „I’m making a big bet,” he said. 

Top psychedelics VCs warn the industry’s boom could turn into a correction and some companies are a 'flash in the pan'

In the third edition of Insider’s psychedelic VC predictions series, top investors said they expect big changes to the landscape. Some said that many companies will fail as the market corrects itself. Others predicted a new era for psychedelic compounds.


An employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel.
REUTERS/Amir Cohen

Executive moves

  • Psychedelics giant Compass Pathways said on Thursday that Guy Goodwin, an emeritus professor of psychiatry at the University of Oxford, would join the company as chief medical officer.
  • Philadelphia 76ers legend Allen Iverson is joining Al Harrington’s California cannabis company, Viola Brands.

Deals, launches, and IPOs

  • London Stock Exchange-listed medical cannabis company Kanabo is acquiring Canada-based Materia Ventures, to create what the companies say is the largest European cannabis company. The financial terms of the transaction were not disclosed. 
  • Cannabis company Verano announced on Monday that it would acquire Nevada-based cannabis company Sierra Well in a $29 million cash and stock deal.
  • Poseidon Garden Ventures, Poseidon Asset Management’s third fund in the cannabis space, said on Monday that it invested in its first three startups: cannabis operator JKL2, cultivation tech company Adaviv, and dispensary tech provider Dispense
  • Psychedelics company Field Trip Health began trading on the Nasdaq on Thursday under the ticker 'FTRP', the latest of a slew of psychedelics companies to list on a US exchange. 
  • Atai Life Sciences, the largest psychedelics company in the world by market cap, said on Wednesday that it had launched InnarisBio, a company focused on nose-to-brain delivery methods for various treatments, alongside the University of Queensland. 

Policy moves

  • Pennsylvania’s Supreme Court ruled that the public has a right to review applications for the state’s medical marijuana licenses, Law 360 reports
  • The House approved a far-reaching spending bill that provides protections to banks that work with legal cannabis companies, allows cannabis sales in Washington D.C., among other cannabis elements, Marijuana Moment reports
  • Colorado Gov. Jared Polis is creating a Cannabis Business Office for the state, to promote social equity in the industry, The Denver Post reports

Research and data

  • Legalizing cannabis federally would reduce arrests but could put some minority entrepreneurs out of business, according to research led by Carnegie Mellon’s Jonathan Caulkins and published in the Boston University Law Review. The analysis shows that expunging records for cannabis possession could advance social equity goals more than other reforms. 
  • CBD can reduce nicotine cravings in rats, according to a new study published in the journal Psychopharmacology. The data suggest that CBD may be a tool to help people alleviate cravings after quitting cigarettes.  
  • Hemp goes 'hot' — as in, exceeds the legal threshold of 0.3% THC — because of genetics and not environmental stress, as was previously thought, according to new research from Cornell University published in the journal Global Change Biology-Bioenergy. Hemp that exceeds the THC threshold can cause farmers to lose their entire crop. 
  • Legalizing cannabis does not lead to more problematic or chaotic use, according to a new study 0f 1,225 cannabis users published in the journal Contemporary Drug Problems


  • Tilray released its fiscal Q4 2021 results on Wednesday, reporting $142.2 million in net revenue and $33.6 million in net income. 

Chart of the week

Canada’s regulated cannabis sales are expected to grow 54% in 2021, according to Headset, double the US growth rate. The cannabis data company said that the Canadian market is newer and smaller than that of the US, making growth more noticeable: 

Chart showing cannabis estimated annual sales growth rate for Canada and US

Estimated annual sales growth rate.
Shayanne Gal/Insider

What we’re reading 

Billionaire Charles Koch on why cannabis should be legal (Forbes)

I gave up alcohol and turned to weed instead, and now I’m a more present and patient parent (Insider)

New York will be buzzing with union jobs thanks to upcoming pot industry (New York Post)

Marijuana helped former NHL champion Darren McCarty beat alcoholism, he says. 'I would’ve been dead without it.' (Insider)

Struggling MedMen Seeks Restructuring, Turnaround (LA Business Journal)

Is medical cannabis really a magic bullet? (The Guardian)

Eighty Six Brand: Delivering Convenience with the Delta-8 THC Disposables Collection – PRNewswire

What are Delta-8 THC Disposable Vape Devices?

Delta-8 THC, or tetrahydrocannabinol, is a minor cannabinoid that occurs naturally in hemp.  An analogue of the traditional Delta-9 THC, Delta-8 produces milder psychoactive effects, allowing you to enjoy a manageable high without the attached anxiety or paranoia you’d normally experience after smoking too much, or too fast.

A Delta-8 THC Disposable encloses the rechargeable battery, the one-gram reservoir that holds the Delta-8 distillate, and a coil system to vaporize the distillate all in one convenient device.  Upon depleting the Delta-8, simply throw the entire device away. This eliminates the need to carry multiple components to achieve the same result: an exceptional Delta-8 experience!

Breaking Down the Eighty Six Brand Disposables

The Eighty Six Brand Delta-8 Disposables collection features five of its most popular strains to date.  Between Berry Slush, Boo Berry, Cereal Killer, Grape Soda, and Jen & Berry’s, the offering is reimagined and reformulated by crossing popular strains.  The result retains both its original flavor profile while also supercharging its functional effects.

For those looking for a more mind-altering experience, Boo Berry is a reimagined Blue Dream crossed with Lemon Haze.  Users experience the same great blueberry-dominant taste with added notes of lemon to keep you creative and alert as you tackle the responsibilities of the day.

For those that want to introduce a little more chill into their daily routines, Jen & Berry’s, formerly known as Gelato, sweetens the ice cream party by crossing Ice Cream Cake into the formulation.  Users taste bold vanilla ice cream sandwiched between the classic chocolate cookie crust to mellow out after an otherwise hectic schedule.

Ready to Take the First Step?

While certain states may have specific regulations and laws pertaining to the purchase and consumption of it, Delta-8 THC is federally legal.  If you live in a state where recreational cannabis is illegal, or simply looking for a way to experience a milder and more manageable psychoactive experience, Eighty Six Brand’s all-new Delta-8 THC Disposables collection proves a viable alternative.

SOURCE Eighty Six Brand

Related Links

Cannabis Client Alert – Week of July 26, 2021 | Dentons – JDSupra – JD Supra

In this week’s edition:

  • Dentons’ Cannabis group congratulates client Botanical Sciences on receiving the top score among applicants for cannabis production licenses in Georgia
  • Major US corporations lobby in support of cannabis legalization and related legislation
  • US Surgeon General Vivek Murthy voices support for decriminalization of cannabis
  • And more…


Surgeon General says stop locking people up for marijuana – US Surgeon General Vivek Murthy voiced support for the decriminalization of cannabis.  “When it comes to decriminalization, I don’t think that there is value to individuals or to society to lock people up for marijuana use,” Murthy said in an appearance on CNN.

Amazon, investment banks, booze, and big tobacco lobbying big on marijuana policy – Several major corporations are showing an active interest in lobbying on behalf of cannabis legalization and related legislation, including e-commerce and cloud-computing giant Amazon, global financial services firm Morgan Stanley, multinational pharma giant Glaxo Smith Kline and tobacco accessories company Turning Point Brands.


CT – Terp Street, a website that provided information on medical cannabis, has shut down after the Connecticut Department of Consumer Protection ordered it to stop using street names for cannabis.  A spokeswoman from the department said the business owners “were asked—and agreed—to remove the street names from their website. They then chose to take down the website entirely.”

GA – Following a competitive bidding process, the Georgia Access to Medical Cannabis Commission selected six recipients of licenses to sell, grow and manufacture medical cannabis oil.  From a field of 69 applicants, Dentons' client Botanical Sciences was the top scorer and one of only two companies to win licenses to cultivate medical cannabis oil on 100,000 square feet of indoor growing space.  Four companies will be licensed for smaller 50,000 square foot operations.

ME – Maine achieved a new record for adult-use cannabis sales in the month of June.  According to the Office of Marijuana Policy, retail dispensaries grossed more than $6.4 million in June, breaking the previous record of $5.3 million in May.  To date, Maine has reported over $29 million in adult-use sales and approximately $2.9 million in sales tax revenue.

NY – New York police are no longer seizing cannabis, making arrests or issuing citations for low-level possession at Albany International and other airports throughout the state.  Bart R. Johnson, a federal security director for 15 upstate airports, indicated that security professionals are concerned with threats such as explosives, knives and guns, as opposed to illegal narcotics.

PA – The Pennsylvania Supreme Court ruled that the state Department of Health may not allow cannabis license applicants to redact their own applications notwithstanding the burden this places on the department.


Colombia boosts budding cannabis industry by removing ban on dry flower exports – Colombia passed a decree removing a prohibition on the export of dried cannabis for medical and other industries.  Under the decree, Colombia will also allow for the expansion of sales of cannabis-based medicines and simplify related regulatory procedures.

HSE to directly pay cost of prescriptions for eligible patients treated under Ministerial License – The Netherlands Department of Health (HSE) announced that its existing refund system for certain eligible patients who obtain cannabis-based prescription products will be replaced by a direct payment system.


New cannabis dispensary roundup – Several cannabis businesses, including Curaleaf, Parallel, Cake House, Cansortium, Trulieve, Deep Roots, Coastal Dispensary, Ack Natural, Strawberry Fields, Ayr Wellness, Verano, and High Tide recently opened new adult-use and medical cannabis retail locations across various states.


Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia and anxious behaviors in a neuropathic pain model – A study found evidence that CBD may be beneficial in the treatment of chronic pain and associated comorbidities such as anxiety.